Inactief instrument

Andere talen Global Blood Therapeutics, Inc.

Aandelen

GBT

US37890U1088

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Pfizer Completes $5.4 Billion Acquisition Of Sickle Cell Disease Drug Innovator	27-10-22
BioPharma Credit Receives $175 Million From Global Blood Therapeutics Investment	06-10-22
Global Blood Therapeutics, Inc.(NasdaqGS:GBT) dropped from S&P Global BMI Index	06-10-22
Global Blood Therapeutics, Inc.(NasdaqGS:GBT) dropped from S&P TMI Index	06-10-22
Global Blood Therapeutics, Inc.(NasdaqGS:GBT) dropped from S&P Biotechnology Select Industry Index	06-10-22
GLOBAL BLOOD THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Regi (form 8-K)	05-10-22
Global Blood Therapeutics, Inc. Announces Cessation of Ted W. Love as Chief Executive Officer	05-10-22
Global Blood Therapeutics, Inc. Announces Executive Changes	05-10-22
Pfizer : finalise l'acquisition de Global Blood Therapeutics	05-10-22
Global Blood Therapeutics, Inc.(NasdaqGS:GBT) dropped from NASDAQ Composite Index	05-10-22
Pfizer Inc. completed the acquisition of Global Blood Therapeutics, Inc. from a group of shareholders.	05-10-22
Global Blood Therapeutics, Inc.(NasdaqGS:GBT) dropped from NASDAQ Biotechnology Index	04-10-22
GLOBAL BLOOD THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders, Other Events (form 8-K)	30-09-22
GLOBAL BLOOD THERAPEUTICS, INC. : Other Events (form 8-K)	23-09-22
GBT Supports the Sickle Cell Disease Treatment Centers Act of 2022	16-09-22
GBT and Sickle Cell Disease Association of America to Host 11th Annual Sickle Cell Disease Therapeutics Conference	08-09-22
Insider Sell: Global Blood Therapeutics	07-09-22
GLOBAL BLOOD THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Global Blood Therapeutics, Inc. - GBT	31-08-22
Insider Sell: Global Blood Therapeutics	19-08-22
Biotech stocks pin bounce back hopes on M&A boost	12-08-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Global Blood Therapeutics, Inc.

Aandelen

GBT

US37890U1088

Andere talen

Filters